JavaScript is disabled for your browser. Some features of this site may not work without it.
Cyclosporine A
Gupta, Aditya K.; Ellis, Charles N.; Goldfarb, Michael T.; Cooper, Kevin D.; Rocher, Leslie; Brown, Marc D.; Baadsgaard, Ole; Voorhees, John J.
1989
Citation:Gupta, Aditya K., Ellis, Charles N., Goldfarb, Michael T., Cooper, Kevin D., Rocher, Leslie, Brown, Marc D., Baadsgaard, Ole, Voorhees, John J. (1989)."Cyclosporine A." Clinics in Dermatology 7(3): 98-110. <http://hdl.handle.net/2027.42/27861>
Abstract: Cyclosporine A (CsA) is a neutral lipophilic compound that was first isolated in the 1970s from the fungal species Tolypocladium inflatum gams. CsA is a cyclic polypeptide that consists of 11 amino acids and that has a molecular weight of 1202 daltons.1 It was found to have potent immunosuppressive properties and was initially used in the late 1970s to prevent organ rejection following transplantation. CsA first became available for general use in North America in 1983 and is now perhaps the most widely used drug to prevent graft rejection in transplantation medicine. The spectrum of conditions for which CsA is now being used has broadened, with recent reports of its benefit in several autoimmune and cutaneous diseases.
